Switzerland· 44307065
Farlutal
A medroxyprogesterone product containing medroxyprogesteroni acetas, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Medroxyprogesterone is registered in 8 of 19 countries.
Countries holding a registration under ATC L02AB02 (medroxyprogesterone), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 6 of them publish a price we can compare per daily dose
Medroxyprogesterone · ATC L02AB02
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of medroxyprogesterone costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- Switzerland: $5.69 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Medroxyprogesterone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.69
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- medroxyprogesteroni acetas
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L02AB02
- ATC class
- Medroxyprogesterone
- Defined daily dose
- 1 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768044307065060 StkCHF 141.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
241 interactions on record for medroxyprogesterone.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Medroxyprogesterone · interactions on record
241 records
- 21 severe
- 213 moderate
- 7 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Medroxyprogesterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFarlutalParanova Oy
- CzechiaPROVERAPfizer, spol. s r.o., Praha
- SpainFARLUTAL 500 mg COMPRIMIDOSPfizer S.L.
- United KingdomFarlutal 500 tabletsPfizer Ltd
- United StatesDepo-ProveraPharmacia & Upjohn Company LLC
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CanadaAA-MEDROXYAA PHARMA INC
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Italy · Depo-Provera, Farlutal
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdf2b0bd-eee3-4ffa-a7a1-0bd632b06523 GET /v1/drugs/fdf2b0bd-eee3-4ffa-a7a1-0bd632b06523?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "medroxyprogesteroni acetas 500 mg",
"valid_from": "1984-03-15",
"limitations": null,
"galenic_form": "Tabl 500 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1984-03-15",
"self_retention_pct": 10
}See everything about medroxyprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.